Rheumatoid Arthritis Flashcards
What is rheumatoid arthritis?
autoimmune condition that causes chronic inflammation of the synovial joints
What is the presentation of Rheumatoid arthritis?
- symmetrical distal polyarthropathy
- more common in women
- swollen painful joints in hands and feet (MCP, PIP joints typically)
- stiffness in am, improves with use
- gradually worsening with larger joint involvement
- presentation insidious, can have systemic upset
- postitive squeeze test - discomfort on squeexing across the metatarsal and metacarpal joints
swan neck and bouttaneire’s deformity - late signs
What are the systemic features associated with RA?
Fatigue
weight loss
flu like illness
muscle aches and weakness
What is Palindromic Rheumatism?
What is the prognosis?
- relapsing/remitting monoarthritis of a few large joints
- resolves on its own after 1-2 days
- RF and anti-CCP +ve may indicate progressing to full RA
What antibodies are present in RA?
what are the NICE guidelines for testing?
RF antibodies
- (usually IgM) present in 70-80%,
- Targets Fc portion portion of patients own IgG
- best test is Rose-Waaler test
- higher titres = more severe disease
Anti-cyclic citrullinated peptide antibody (Anti-CCP)
- more sensitive and specific than RF
- can be detected up to 10 years before RA onset
NICE: Test RF negative for anti-CCP
Which joints are commonly affected with RA
- PIP
- MCP
- wrists and ankles
- cervical spine - atlantoaxial subluxation can cause spinal cord compression
- large joints later disease - knee, hips, shoulders
What can atlatoxial subluxation lead to?
can lead to spinal cord compression - emergency
What are the signs in the hands seen in RA?
- boggy feeling around joints on palptation (due to inflamamation and swelling)
- Z-shaped deformity of the thumb
- Swan neck deformity (hyperextended PIP with flexed DIP)
- Boutonnieres deformity (hyperextended DIP with flexed PIP)
- Ulnar deviation of the fingers at the knuckle (MCP joints)
What are extra-articular manifestations of RA?
- RESP: Pulmonary fibrosis, effusion and nodules, Bronchiolitis Obliteran
- EYES: Keratonconjunctivitis sicca ,Episcleritis, scleritis, corneal ulceration, keratitis
- HEART: pericardial effusion, pericarditis, IHD
- Felty’s syndrome (RA, Neutropenia, splenomegaly)
- Secondary Sjogren’s
- Carpel Tunnel
- Amyloidosis
- Anaemia of chronic disease
What investigations would you do for RA?
- RF
- Anti-CCP (if RF negative)
Inflammatory markers: ESR , - CRP - X-ray of hands and feet
- USS of joints - to evaluate and confirm synovitis
What are X-ray changes seen in RA?
- soft tissue swelling
- Loss of joint space
- Juxta-articular oesteopenia/osteoporosis
- Bony erosions and subluxation - later stage
How is RA diagnosed?
NICE recommends clinical diagnosis more important
Criteria from american college
scored on:
1. Joint involvement (more and smaller joints score higher)
2. Serology (RF, Anti-CCP)
3. Inflammatory markers - ESR, CRP
4. duration of symptoms (more or less than 6 weeks)
> = 6 –> RA
How is disease activity monitored in RA?
DAS28 - disease activity score
- based on assessment of 28 joints
- points given for swollen joints, tender joints and ESR/CRP
Treatment should be escalated until control is reached (Treat to target)
How is RA managed?
What do the biologics carry a risk of?
- Initial therapy: DMARD (methotrexate, leflunomide, sulfasalazine, hydroxychlorquinone)
+/- short course of bridging prednisolone (starting earlier has better prognosis) - Flares: Steroids - oral or IM
- Symptomatic relief: NSAIDs
- Specialist physio, surgery (manage deformities)
Biologics are alternatives to DMARDs if patient unresponsive to 2 different ones:
- TNF-alpha inhbitors - Adalimumab, Infliximab, etanercept
- Ritixumab (Anti-CD20, results in B cell depletion)
All immunosuppressant -
Infections
reactivation of dormant infections e.g TB, Hep B
What is the escalation of drug management in RA?
1st line: DMARD. hydroxychloroquinone for mild
2nd line: combination of DMARD
3rd line: Methotrexate + biologic (usually TNF-alpha inhibitor
4th Line: Methotrexate + rituximab